85 related articles for article (PubMed ID: 24299818)
1. Telmisartan complex augments solubility, dissolution and drug delivery in prostate cancer cells.
Kaur M; Bhatia RK; Pissurlenkar RR; Coutinho EC; Jain UK; Katare OP; Chandra R; Madan J
Carbohydr Polym; 2014 Jan; 101():614-22. PubMed ID: 24299818
[TBL] [Abstract][Full Text] [Related]
2. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
Sangwai M; Vavia P
Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
[TBL] [Abstract][Full Text] [Related]
3. Improved pH-dependent drug release and oral exposure of telmisartan, a poorly soluble drug through the formation of drug-aminoclay complex.
Yang L; Shao Y; Han HK
Int J Pharm; 2014 Aug; 471(1-2):258-63. PubMed ID: 24834880
[TBL] [Abstract][Full Text] [Related]
4. The effect of mechanical grinding on the formation, crystalline changes and dissolution behaviour of the inclusion complex of telmisartan and β-cyclodextrins.
Borba PA; Pinotti M; Andrade GR; da Costa NB; Olchanheski Junior LR; Fernandes D; de Campos CE; Stulzer HK
Carbohydr Polym; 2015 Nov; 133():373-83. PubMed ID: 26344293
[TBL] [Abstract][Full Text] [Related]
5. Soluble telmisartan bearing poly (ethylene glycol) conjugated chitosan nanoparticles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in human cervical cancer cells.
Sharma A; Jyoti K; Bansal V; Jain UK; Bhushan B; Madan J
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():69-76. PubMed ID: 28024639
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
7. Soluble curcumin amalgamated chitosan microspheres augmented drug delivery and cytotoxicity in colon cancer cells: In vitro and in vivo study.
Jyoti K; Bhatia RK; Martis EAF; Coutinho EC; Jain UK; Chandra R; Madan J
Colloids Surf B Biointerfaces; 2016 Dec; 148():674-683. PubMed ID: 27701049
[TBL] [Abstract][Full Text] [Related]
8. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
Hu L; Zhang H; Song W; Gu D; Hu Q
Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
[TBL] [Abstract][Full Text] [Related]
9. The influence of hydroxypropyl-β-cyclodextrin on the solubility, dissolution, cytotoxicity, and binding of riluzole with human serum albumin.
Wang L; Yan J; Li Y; Xu K; Li S; Tang P; Li H
J Pharm Biomed Anal; 2016 Jan; 117():453-63. PubMed ID: 26454338
[TBL] [Abstract][Full Text] [Related]
10. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation.
Qiu N; Cheng X; Wang G; Wang W; Wen J; Zhang Y; Song H; Ma L; Wei Y; Peng A; Chen L
Carbohydr Polym; 2014 Jan; 101():623-30. PubMed ID: 24299819
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of a novel β-cyclodextrin derivative for oral insulin delivery and absorption.
Zhang L; Zhang Z; Li N; Wang N; Wang Y; Tang S; Xu L; Ren Y
Int J Biol Macromol; 2013 Oct; 61():494-500. PubMed ID: 23994793
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterisation and antitumour activity of β-, γ- and HP-β-cyclodextrin inclusion complexes of oxaliplatin.
Zhang D; Zhang J; Jiang K; Li K; Cong Y; Pu S; Jin Y; Lin J
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():501-8. PubMed ID: 26254603
[TBL] [Abstract][Full Text] [Related]
14. Sigma-2 receptor ligand anchored telmisartan loaded nanostructured lipid particles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in prostate cancer cells.
Puri R; Kaur Bhatia R; Shankar Pandey R; Kumar Jain U; Katare OP; Madan J
Drug Dev Ind Pharm; 2016 Dec; 42(12):2020-2030. PubMed ID: 27184705
[TBL] [Abstract][Full Text] [Related]
15. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
16. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
[TBL] [Abstract][Full Text] [Related]
18. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release.
Tran PH; Tran HT; Lee BJ
J Control Release; 2008 Jul; 129(1):59-65. PubMed ID: 18501462
[TBL] [Abstract][Full Text] [Related]
19. Non-inclusion complexes between riboflavin and cyclodextrins.
de Jesus MB; Fraceto LF; Martini MF; Pickholz M; Ferreira CV; de Paula E
J Pharm Pharmacol; 2012 Jun; 64(6):832-42. PubMed ID: 22571261
[TBL] [Abstract][Full Text] [Related]
20. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
